An External Control Arm Study in Non-Small Cell Lung Cancer

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 8 → 11 locations
    • Eligibility criteria expanded, about 9 words
  2. Re-verified, no change to tracked fieldsv8
  3. Enrollment increased: 550 → 650 participants
    • Trial arms changed: 9 → 11
    • Eligibility criteria shortened, about 11 words
    • Study title expanded, about 3 words
    v7
  4. Study sites: 7 to 8v6
  5. Trial sites expanded: 3 → 7 locationsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 1 to 3v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2025 to Jan 7, 2026
    v3
  3. Enrollment target: 350 to 550v2 Show 4 more changesShow less
    • Start date: Sep 2025 to Dec 2025
    • Eligibility criteria shortened, about 28 words
    • Study arms: 7 to 9
    • Study title shortened, about 1 word
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A study to create control arms using current and future information in patients with lung cancer.
Trial Details
NCT Number NCT07174388
Lead Sponsor N-Power Medicine
Conditions
(from sponsor)		 Non Small Cell Lung Cancer
Related terms Carcinoma, Non-Small-Cell Lung
Enrollment 650 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov